Efficacy and Safety of Ruxolitinib Cream for the Treatment of Moderate to Severe Chronic Hand Eczema: Results From a 16-Week, Multicenter, Randomized, Double-Blind Study

Name: Efficacy and Safety of Ruxolitinib Cream for the Treatment of Moderate to Severe Chronic Hand Eczema: Results From a 16-Week, Multicenter, Randomized, Double-Blind Study
Creator: Philippa Halden
Published: 2025-08-13T15:42:56.858Z
Keywords: Ruxolitinib, Eczema, Janus Kinase

Halden, Philippa

doi:10.17632/vf464fms2b.1

Efficacy and Safety of Ruxolitinib Cream for the Treatment of Moderate to Severe Chronic Hand Eczema: Results From a 16-Week, Multicenter, Randomized, Double-Blind Study

Published: 13 August 2025| Version 1 | DOI: 10.17632/vf464fms2b.1

Contributor:

Philippa Halden

Description

Supplemental data for an article published in the Journal of the American Academy of Dermatology

Efficacy and Safety of Ruxolitinib Cream for the Treatment of Moderate to Severe Chronic Hand Eczema: Results From a 16-Week, Multicenter, Randomized, Double-Blind Study

Description

Files

Categories

Licence